{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:07:50Z","timestamp":1791389270693,"version":"4.3.3"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271883"],"award-info":[{"award-number":["82271883"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81972479"],"award-info":[{"award-number":["81972479"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2024A1515010310"],"award-info":[{"award-number":["2024A1515010310"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-025-01121-1","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:43:12Z","timestamp":1761122592000},"page":"1971-1986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Machine learning constructs a ferroptosis related signature for predicting prognosis and drug sensitivity in lung cancer"],"prefix":"10.1007","volume":"48","author":[{"given":"Zihao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benxin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1893-7649","authenticated-orcid":false,"given":"Zhengzhi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"1121_CR1","unstructured":"S. Hyuna, F. Jacques, S. Rebecca, L.L. Mathieu, S. Isabelle, J. Ahmedin, B. J. C. C. J. C. Freddie, global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, (2021)"},{"key":"1121_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"T William","year":"2015","unstructured":"T. William, D.B. Elisabeth, N. Andrew, G.Y. Yasushi, A. John, H.M.B. Mary Beth, C. Lucian, R.D. Sanja, D. Edwina, F. Douglas, B.G. Kim, H. Fred, R.I. Yuichi, K. Keith, M.N. Masayuki, P. Giuseppe, P. Charles, A.T. Ming Sound, W.J.J.T.O. Ignacio, The 2015 world health organization classification of lung tumors: impact of Genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. 10, 1243\u20131260 (2015)","journal-title":"J. Thorac. Oncol."},{"key":"1121_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"H Roy","year":"2018","unstructured":"H. Roy, S.M. Daniel, B.J.N. Chris, The biology and management of non-small cell lung cancer. Nature. 553, 446\u2013454 (2018)","journal-title":"Nature"},{"key":"1121_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s13046-019-1413-7","volume":"38","author":"Y Chen","year":"2019","unstructured":"Y. Chen, Y. Mi, X. Zhang, Q. Ma, Y. Song, L. Zhang, D. Wang, J. Xing, B. Hou, H.J.J.O.E. Li, Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK\/ATF4\/HSPA5 pathway in glioma cells. J. Exp. Clin. Cancer Res. 38, 402 (2019)","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1121_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10495-022-01795-0","volume":"28","author":"M Luo","year":"2023","unstructured":"M. Luo, J. Yan, X. Hu, H. Li, H. Li, Q. Liu, Y. Chen, Z.J.A. Zou, Targeting lipid metabolism for ferroptotic cancer therapy. Apoptosis. 28, 81\u2013107 (2023)","journal-title":"Apoptosis"},{"key":"1121_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"Y Wan Seok","year":"2014","unstructured":"Y. Wan Seok, S. Rohitha, W. Matthew, E.S. Kenichi, S. Rachid, V. Vasanthi, S.C. Jaime, H.C. Paul, A.S. Alykhan, F.C. Clary, B.B. Lewis, M.G. Albert, W.C. Virginia, W.S. Stuart, L.S.J.C. Brent, Regulation of ferroptotic cancer cell death by GPX4. Cell. 156, 317\u2013331 (2014)","journal-title":"Cell"},{"key":"1121_CR7","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s10495-024-01985-y","volume":"29","author":"Y Luo","year":"2024","unstructured":"Y. Luo, X. Liu, Y. Chen, Q. Tang, C. He, X. Ding, J. Hu, Z. Cai, X. Li, H.J.A. Qiao, Targeting PAX8 sensitizes ovarian cancer cells to ferroptosis by inhibiting glutathione synthesis. Apoptosis. 29, 1499\u20131514 (2024)","journal-title":"Apoptosis"},{"key":"1121_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"Z Chen","year":"2022","unstructured":"Z. Chen, L. Xinyin, J. Shidai, C. Yi, G.J.M.C. Renhua, Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol. Cancer. 21, 47 (2022)","journal-title":"Mol. Cancer"},{"key":"1121_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","volume":"13","author":"T Rong","year":"2020","unstructured":"T. Rong, X. Jin, Z. Bo, L. Jiang, L. Chen, H. Jie, M. Qingcai, Y. Xianjun, S.J.J.H.O. Si, Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J. Hematol. Oncol. 13, 110 (2020)","journal-title":"J. Hematol. Oncol."},{"key":"1121_CR10","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"Q Daniela","year":"2013","unstructured":"Q. Daniela, F.J.J.N.M. Johanna, Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423\u20131437 (2013)","journal-title":"Nat. Med."},{"key":"1121_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"H Behrouz","year":"2019","unstructured":"H. Behrouz, V. Peter, V.B.J.C.C. Tom, Targeting ferroptosis to iron out cancer. Cancer Cell. 35, 830\u2013849 (2019)","journal-title":"Cancer Cell."},{"key":"1121_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"G Peter","year":"2016","unstructured":"G. Peter, C. Kari, C. John, R.-P. Ramon, A. Hisao, E. Wilfried, E.E.N. Andrew, G.G. Patti, M. Alan, B.J.J.T.O. Vanessa, The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J. Thorac. Oncol. 11, 39\u201351 (2016)","journal-title":"J. Thorac. Oncol."},{"key":"1121_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jtho.2016.01.025","volume":"11","author":"D Frank","year":"2016","unstructured":"D. Frank, C.F. Wilbur, A.N. Andrew, G.G. Nicolas, A. Douglas, A.T. William, D.M. Peter, J.M. Edith, M.D. Jessica, S.T. Lynn, T.R. Valerie, W.A. Hisao, J. T. O. Ram\u00f3n, the IASLC lung cancer staging project: background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors in the forthcoming eighth edition of the TNM classification for lung cancer. J. Thorac. Oncol. 11, 651\u2013665 (2016)","journal-title":"J. Thorac. Oncol."},{"key":"1121_CR14","first-page":"255","volume":"389","author":"R Achim","year":"2016","unstructured":"R. Achim, B. Fabrice, W. Daniel, P. Keunchil, C. Fortunato, V.P. Joachim, G. Shirish, M.H. Toyoaki, K. Dariusz, M.D. Manuel Cobo, C. Diego, L.L. Joseph, P. Jonathan, B. Carlos, K. Fairooz, F. Osvaldo Ar\u00e9n, D.M. Filippo, T. Hande, L. Jong-Seok, B. Marcus, K. Marcin, H. Pei, C. Daniel, S.S. Alan, G.J.L. David, Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet. 389, 255\u2013265 (2016)","journal-title":"Lancet"},{"key":"1121_CR15","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/s41591-018-0134-3","volume":"24","author":"G David","year":"2018","unstructured":"G. David, R.P. Sarah, M.K. Marcin, S. Erica, Z. Wei, L. Yan, R. Achim, F. Louis, O. Geoff, M. Christine, L. Daniel, S.L. Doron, S. Jacob, A. Lukas, R. Todd, C. Craig, A.H. Priti, S.S. Alan, B. Marcus, F. David, M. Tony, S.J.N.M. David, Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with Atezolizumab. Nat. Med. 24, 1441\u20131448 (2018)","journal-title":"Nat. Med."},{"key":"1121_CR16","doi-asserted-by":"publisher","first-page":"D571","DOI":"10.1093\/nar\/gkac935","volume":"51","author":"N Zhou","year":"2023","unstructured":"N. Zhou, X. Yuan, Q. Du, Z. Zhang, X. Shi, J. Bao, Y. Ning, D.-D. D. H. D. O. N. G. Ferrdb, FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Vol Nucleic Acids Res. 51, D571\u2013D582 (2023). Nucleic acids research","journal-title":"Vol Nucleic Acids Res."},{"key":"1121_CR17","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2012","unstructured":"T. Barrett, S.E. Wilhite, P. Ledoux, C. Evangelista, I.F. Kim, M. Tomashevsky, K.A. Marshall, K.H. Phillippy, P.M. Sherman, a. R. Holko, NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res. 41, D991\u2013D995 (2012)","journal-title":"Nucleic Acids Res."},{"key":"1121_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"L Peter","year":"2008","unstructured":"L. Peter, H.J.B.B. Steve, WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9, 559 (2008)","journal-title":"BMC Bioinform."},{"key":"1121_CR19","first-page":"Article17","volume":"4","author":"B Zhang","year":"2006","unstructured":"B. Zhang, S. Horvath, A general framework for weighted gene coexpression network analysis. Stat. Appl. Genet. Mol. Biol. 4, Article17 (2006)","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"1121_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/biostatistics\/kxu010","volume":"15","author":"I Hemant","year":"2014","unstructured":"I. Hemant, G. Thomas, A.K. Udaya, B.M. Richard, D.G. Stephen, J.L.J.B. Bryan, Random survival forests for competing risks. Biostatistics. 15, 757\u2013773 (2014)","journal-title":"Biostatistics"},{"key":"1121_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"H. Zou, S. S. S. B. S. M. Hastie, regularization and variable selection via the elastic net. J. R Stat. Soc. B 67, 301\u2013320 (2005)","journal-title":"J. R Stat. Soc. B"},{"key":"1121_CR22","doi-asserted-by":"crossref","unstructured":"T.J.S.M. R, The lasso method for variable selection in the Cox model. Stat. Med. 16, 385\u2009\u2013\u200995 (1997)","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3"},{"key":"1121_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-9-14","volume":"9","author":"H Binder","year":"2008","unstructured":"H. Binder, M.J.B.B. Schumacher, Allowing for mandatory covariates in boosting Estimation of sparse high-dimensional survival models. BMC Bioinform. 9, 1\u201310 (2008)","journal-title":"BMC Bioinform."},{"key":"1121_CR24","first-page":"457","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"E.L. Kaplan, Meier, Nonparametric Estimation Incomplete Observations J. Am. Stat. Assoc. 53, 457\u2013481 (1958)","journal-title":"Nonparametric Estimation Incomplete Observations J. Am. Stat. Assoc."},{"key":"1121_CR25","first-page":"92","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"P.J. Heagerty, Y.J.B. Zheng, Survival Model. Predictive Accuracy ROC Curves Biometrics. 61, 92\u2013105 (2005)","journal-title":"Survival Model. Predictive Accuracy ROC Curves Biometrics"},{"key":"1121_CR26","doi-asserted-by":"crossref","unstructured":"R.L. Prentice, Introduction to Cox, Regression models and life-tables. (Springer Series in Statistics, 1992), pp. 519\u2013526 (1972)","DOI":"10.1007\/978-1-4612-4380-9_36"},{"key":"1121_CR27","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"I Alexia","year":"2008","unstructured":"I. Alexia, S. Deborah, R. Ganesh, V.P.J.J.C.O. Katherine, How to build and interpret a nomogram for cancer prognosis. J. Clin. Oncol. 26, 1364\u20131370 (2008)","journal-title":"J. Clin. Oncol."},{"key":"1121_CR28","doi-asserted-by":"crossref","unstructured":"A. Angel, L. Naom, S. Nabet-Levy, D.J.B. Aran, xCell 2.0: Robust algorithm for cell type proportion estimation predicts response to immune checkpoint blockade. bioRxiv. (2024)","DOI":"10.1101\/2024.09.06.611424"},{"key":"1121_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"M Aaron","year":"2015","unstructured":"M. Aaron, C. Newman, R. Long, Liu, J. Michael, Green, F.J.N. Andrew, Gentles, Weiguo, Methods, Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods. 12, 453\u2013457 (2015)","journal-title":"Nat. Methods"},{"key":"1121_CR30","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, J. P. O. T. N. a. O. S. Lander, gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A 102, 15545\u201315550 (2005)","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"1121_CR31","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"P. Jiang, S. Gu, D. Pan, J. Fu, A. Sahu, X. Hu, Z. Li, N. Traugh, X. Bu, B.J.N.M. Li, Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558 (2018)","journal-title":"Nat. Med."},{"key":"1121_CR32","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","volume":"15","author":"P Geeleher","year":"2014","unstructured":"P. Geeleher, N.J. Cox, R.J.G.B. Huang, 15,3, clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol. 15, R47 (2014)","journal-title":"Genome Biol."},{"key":"1121_CR33","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.7150\/jca.38981","volume":"11","author":"H Hai","year":"2020","unstructured":"H. Hai, T. Wenzhi, C. Yungu, Z. Ming, J. Huan, H. Ting, Z. Zhengzhi, X.J.J.C. Qing, The combination of PKM2 overexpression and M2 macrophages infiltration confers a poor prognosis for PDAC patients. J. Cancer. 11, 2022\u20132031 (2020)","journal-title":"J. Cancer"},{"key":"1121_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.canlet.2019.08.008","volume":"464","author":"Q Ni","year":"2019","unstructured":"Q. Ni, H. Yu-Fang, Z. Si-Ming, Z. Yong-Tao, H. Guo-Dong, J. Ming, H. Wei-Xing, Z. Jie, L. Hong-Ling, A. Xiang, X. Hao-Ming, L. Jia, Y. Yu-Yang, H. Zhi-Min, Z. Zheng-Zhi, Hong-Sheng, Cullin7 enhances resistance to trastuzumab therapy in Her2 positive breast cancer via degrading IRS-1 and downregulating IGFBP-3 to activate the PI3K\/AKT pathway. Cancer Lett. 464, 25\u201336 (2019)","journal-title":"Cancer Lett."},{"key":"1121_CR35","unstructured":"R.C.T.R. Null, R. Team, R.C.T. Null, T. Core Writing, R. Null, R. Team, R.D.C.T. Null, R. Core, R. Team, R. D. C. J. C. Team, R: A language and environment for statistical computing Lecture Notes in Statistics, 12\u201321 (2011)"},{"key":"1121_CR36","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(95)91748-9","volume":"346","author":"JM Bland","year":"1995","unstructured":"J.M. Bland, D.G.J.T.L. Altman, Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet. 346, 1085\u20131087 (1995)","journal-title":"Lancet"},{"key":"1121_CR37","first-page":"9","volume":"10","author":"D Scott","year":"2013","unstructured":"D. Scott, J.S.J.N.C.B. Brent, The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9\u201317 (2013)","journal-title":"Nat. Chem. Biol."},{"key":"1121_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"AMBCABJAB D","year":"2000","unstructured":"A.M.B.C.A.B.J.A.B. D, B. H, C. J M, D. D. A P, D.S.S. K, E. J T, H.M. A, H. D P, I.-T. L, K. A, L. S, M.J.C.R. J E, J. N. G. G, gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25, 25\u201329 (2000)","journal-title":"Nat. Genet."},{"key":"1121_CR39","first-page":"D607","volume":"47","author":"S Damian","year":"2018","unstructured":"S. Damian, G. Annika, L.L. David, J. Alexander, W. Stefan, H.-C. Jaime, S. Milan, D. Nadezhda, T.M. John, H.B. Peer, J. Lars, a. R. Christian Von, STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613 (2018)","journal-title":"Nucleic Acids Res."},{"key":"1121_CR40","doi-asserted-by":"crossref","unstructured":"S. Sijin, Y. Yannan, Y. Zhenlin, W. Juhong, L. Renda, T. He, T. Fengwei, X. Qi, G. Yibo, H. J. F. C. D. B. Jie, ferroptosis characterization in lung adenocarcinomas reveals prognostic signature with immunotherapeutic implication. Front. Cell. Dev. Biol. 9, (2021)","DOI":"10.3389\/fcell.2021.743724"},{"key":"1121_CR41","doi-asserted-by":"crossref","unstructured":"M. Ti-Wei, Y. De-Qing, C. Fang-Ying, Z. Qi, C.J.B.R. Xin, A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma. Biosci. Rep. 42, (2022)","DOI":"10.1042\/BSR20212835"},{"key":"1121_CR42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1186\/s12885-021-08541-w","volume":"21","author":"L Taisheng","year":"2021","unstructured":"L. Taisheng, L. Honglian, Z. Jinye, H. Xiaoshan, Z.J.B.C. Jian, Molecular identification of an immunity- and Ferroptosis-related gene signature in non-small cell lung cancer. BMC Cancer. 21, 783 (2021)","journal-title":"BMC Cancer"},{"key":"1121_CR43","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12931-023-02429-y","volume":"24","author":"M Aijia","year":"2023","unstructured":"M. Aijia, F. Zhongxue, L. Yang, W. Qin, X. Huaiyu, D. Meiling, C. Jiangli, W. Zhenling, Y. Jing, K.J.R.R. Yan, Ferroptosis-related signature and immune infiltration characterization in acute lung injury\/acute respiratory distress syndrome. Respir Res. 24, 154 (2023)","journal-title":"Respir Res."},{"key":"1121_CR44","first-page":"12608","volume":"16","author":"Z Chuan","year":"2024","unstructured":"Z. Chuan, S. Yingying, W. Hongrui, D. Dan, H. Xin, S. Shuyou, S. Yue, Z. Peng, Y.J.A. Ming, Characterization of a ferroptosis-related gene signature predicting survival and immunotherapeutic response in lung adenocarcinoma. Aging (Albany NY). 16, 12608\u201312622 (2024)","journal-title":"Aging (Albany NY)"},{"key":"1121_CR45","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"A. Liberzon, C. Birger, H. Thorvaldsd\u00f3ttir, M. Ghandi, J.P. Mesirov, Tamayo, the molecular signatures database (MSigDB) hallmark gene set collection. Cell. Syst. 1, 417\u2013425 (2015)","journal-title":"Cell. Syst."},{"key":"1121_CR46","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"D. Hanahan, R.J.C. Weinberg, Hallmarks of cancer: the next generation. Cell. 144, 646\u2013674 (2011)","journal-title":"Cell"},{"key":"1121_CR47","doi-asserted-by":"crossref","unstructured":"P. Padmanee, Sharma, A.J. James, Science, The future of immune checkpoint therapy. (2015)","DOI":"10.1126\/science.aaa8172"},{"key":"1121_CR48","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"F.S. Collins, H.J.N.E.J.O.M. Varmus, A new initiative on precision medicine. N Engl. J. Med. 372, 793\u2013795 (2015)","journal-title":"N Engl. J. Med."},{"key":"1121_CR49","doi-asserted-by":"crossref","unstructured":"M.E. Ritchie, P. Belinda, W. Di, H. Yifang, C.W. Law, S. Wei, G. K. J. N. A. R. Smyth, Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015)","DOI":"10.1093\/nar\/gkv007"},{"key":"1121_CR50","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"D Scott","year":"2012","unstructured":"D. Scott, J.L. Kathryn, M.L. Michael, R.S. Rachid, Z. Eleina, M.G. Caroline, E.P. Darpan, N.B. Andras, J.C. Alexandra, M.Y. Wan Seok, M. 3 Barclay, Brent R, ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 149, 1060\u20131072 (2012)","journal-title":"Cell"},{"key":"1121_CR51","first-page":"1060","volume":"149","author":"G Lorenzo","year":"2018","unstructured":"G. Lorenzo, V. Ilio, A. Stuart, A.A. John, M.A. Dieter, A. Patrizia, A. Emad, S.A. Lucia, A. Ivano, A. David, Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death. Cell. 149, 1060\u20131072 (2018)","journal-title":"Cell"},{"key":"1121_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"T Daolin","year":"2021","unstructured":"T. Daolin, C. Xin, K. Rui, K.J.C.R. Guido, Ferroptosis: molecular mechanisms and health implications. Cell. Res. 31, 107\u2013125 (2021)","journal-title":"Cell. Res."},{"key":"1121_CR53","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Weimin","year":"2019","unstructured":"W. Weimin, G. Michael, C. Jae Eun, G. Miguel, K. Paul, D.J. Jeffrey, K.L. Peng, L. Xueting, K. Ilona, S. Amanda et al., CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 569, 270\u2013274 (2019)","journal-title":"Nature"},{"key":"1121_CR54","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s10495-022-01766-5","volume":"27","author":"L Liu","year":"2022","unstructured":"L. Liu, H. Jin, M. Dong, J. Tian, H. Li, Q. Liu, Y. Chen, a. a. I. J. O. P. C. D. Zou, identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma. Apoptosis. 27, 946\u2013960 (2022)","journal-title":"Apoptosis"},{"key":"1121_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"J. Fu, K. Li, W. Zhang, C. Wan, J. Zhang, P. Jiang, X.S.J.G.M. Liu, Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 12, 21 (2020)","journal-title":"Genome Med."},{"key":"1121_CR56","doi-asserted-by":"crossref","unstructured":"Y. Bicheng, F. Jun, X. Lei, Z. Yu, L. Peng, J. Aimin, X. Jiaheng, L. Qifan, L. Xiaoqing, T. Jiaxiong, Z. Songyun, Z. Wenhang, R. Chuanli, L. Haoran, Z.J.I. Pengpeng, iMLGAM: integrated machine learning and genetic algorithm-driven multiomics analysis for pan-cancer immunotherapy response prediction. Imeta. 4, (2025)","DOI":"10.1002\/imt2.70011"},{"key":"1121_CR57","doi-asserted-by":"crossref","unstructured":"W. Yue, W. Dongliang, L. Yuqing, L. Xiyu, H. Pinzheng, J. Mingming, H.J.B.P. Gang, Regulatory mechanism of \u03b1-hederin upon cisplatin sensibility in NSCLC at safe dose by destroying GSS\/GSH\/GPX2 axis-mediated glutathione oxidation-reduction system. Biomed. Pharmacother 150, (2022)","DOI":"10.1016\/j.biopha.2022.112927"},{"key":"1121_CR58","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s42003-024-06452-7","volume":"7","author":"B Yunyi","year":"2024","unstructured":"B. Yunyi, S. Guangyao, L. Jiaqi, H. Zhengyang, S. Qihai, S. Haochun, W. Qun, B. Guoshu, Z.J.C.B. Cheng, Retinoic acid receptor alpha inhibits ferroptosis by promoting thioredoxin and protein phosphatase 1F in lung adenocarcinoma. Commun. Biol. 7, 751 (2024)","journal-title":"Commun. Biol."},{"key":"1121_CR59","doi-asserted-by":"crossref","unstructured":"Z. Pengpeng, W. Dingli, Z. Guangyao, J. Shuai, Z. Ge, Z. Lianmin, Z.J.J.I.C. Zhenfa, Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma. J. Immunother Cancer 13, (2025)","DOI":"10.1136\/jitc-2024-010787"},{"key":"1121_CR60","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1016\/j.apsb.2023.03.025","volume":"13","author":"Y Luo","year":"2023","unstructured":"Y. Luo, Y. Chen, H. Jin, B. Hou, H. Li, X. Li, L. Liu, Y. Zhou, Y. Li, Y. Song, Q. Liu, Z.J. a., P.S.B. Zou, The suppression of cervical cancer ferroptosis by macrophages: the Attenuation of ALOX15 in cancer cells by macrophages-derived exosomes. Acta Pharm. Sin B 13, 2645\u20132662 (2023)","journal-title":"Acta Pharm. Sin B"},{"key":"1121_CR61","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s40364-024-00686-7","volume":"12","author":"F Jiaqi","year":"2024","unstructured":"F. Jiaqi, Z. Pengpeng, W. Dingli, L. Yuting, T.J.B.R. Jiaxiong, New strategies for lung cancer diagnosis and treatment: applications and advances in nanotechnology. Biomark. Res. 12, 136 (2024)","journal-title":"Biomark. Res."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01121-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01121-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01121-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T10:04:47Z","timestamp":1765447487000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01121-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01121-1","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}